See more : Gjensidige Forsikring ASA (GJNSY) Income Statement Analysis – Financial Results
Complete financial analysis of Maja Agung Latexindo Tbk. (SURI.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Maja Agung Latexindo Tbk., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Solteam Incorporation (3484.TWO) Income Statement Analysis – Financial Results
- Concord New Energy Group Limited (CWPWF) Income Statement Analysis – Financial Results
- Chang Jiang Shipping Group Phoenix Co.,Ltd (000520.SZ) Income Statement Analysis – Financial Results
- Kumho HT, Inc (214330.KS) Income Statement Analysis – Financial Results
- Planet Home Investment AG (ILK1.SG) Income Statement Analysis – Financial Results
Maja Agung Latexindo Tbk. (SURI.JK)
Industry: Medical - Instruments & Supplies
Sector: Healthcare
About Maja Agung Latexindo Tbk.
PT Maja Agung Latexindo Tbk is engaged in the filed of manufacturing, especially producing medical gloves. The business activities of the company is to engage in rubber goods industry to support health needs, including contraceptive covers, pacifiers, compression devices, medical gloves and urinary catheters.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 81.72B | 93.33B | 338.13B | 313.37B |
| Cost of Revenue | 66.78B | 77.97B | 282.50B | 261.10B |
| Gross Profit | 14.93B | 15.36B | 55.63B | 52.28B |
| Gross Profit Ratio | 18.28% | 16.46% | 16.45% | 16.68% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.23B | 1.34B | 1.85B | 1.12B |
| Selling & Marketing | 1.32B | 1.93B | 11.10B | 8.87B |
| SG&A | 4.55B | 3.27B | 12.94B | 9.99B |
| Other Expenses | 9.64B | 584.45M | 3.90B | 1.40B |
| Operating Expenses | 14.19B | 20.52B | 21.13B | 18.56B |
| Cost & Expenses | 80.97B | 98.48B | 303.62B | 279.66B |
| Interest Income | 13.63M | 1.29M | 207.20M | 162.64M |
| Interest Expense | 56.18M | 76.63M | 222.27M | 116.92M |
| Depreciation & Amortization | 7.31M | 50.16M | 77.30M | 79.98M |
| EBITDA | 978.07M | -5.11B | 34.58B | 33.79B |
| EBITDA Ratio | 1.20% | -23.44% | 10.23% | 10.78% |
| Operating Income | 744.64M | 1.20B | 32.24B | 33.71B |
| Operating Income Ratio | 0.91% | 1.28% | 9.53% | 10.76% |
| Total Other Income/Expenses | 6.64B | 12.01B | 1.79B | 3.26B |
| Income Before Tax | 7.39B | 13.21B | 34.03B | 36.98B |
| Income Before Tax Ratio | 9.04% | 14.16% | 10.06% | 11.80% |
| Income Tax Expense | 1.92B | 2.99B | 7.60B | 8.15B |
| Net Income | 5.47B | 10.23B | 26.43B | 28.82B |
| Net Income Ratio | 6.69% | 10.96% | 7.82% | 9.20% |
| EPS | 1.17 | 1.61 | 4.17 | 4.55 |
| EPS Diluted | 1.17 | 1.61 | 4.17 | 4.55 |
| Weighted Avg Shares Out | 4.66B | 6.33B | 6.33B | 6.33B |
| Weighted Avg Shares Out (Dil) | 4.66B | 6.33B | 6.33B | 6.33B |
Source: https://incomestatements.info
Category: Stock Reports